Clinical trial

Higher Dose Preoperative taMOxifen in Premenopausal bREast Cancer Patients

NCT04997941

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2021-10-21

PhasePHASE2

Study timeline

Study start (actual)2021-10-21Date precision: day

Registry last updated2024-04-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Premenopausal Breast Cancerunresolved

Hormone Receptor-positive Breast Cancerunresolved

Interventions

Tamoxifen Oral ProductDRUG

Assessment of Ki-67DIAGNOSTIC_TEST

SurgeryPROCEDURE

Sponsors & collaborators

Seoul National University Hospitallead sponsor

Mapped research locations

SeoulSouth Korea1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04997941 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.